Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;53(1):233-242.
doi: 10.4143/crt.2020.159. Epub 2020 Sep 14.

A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy

Zhengjie Ou  1 , Dan Zhao  1 , Bin Li  1 , Yating Wang  1 , Shuanghuan Liu  1 , Yanan Zhang  1
Affiliations

A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy

Zhengjie Ou et al. Cancer Res Treat. 2021 Jan.

Abstract

Purpose: This study aimed to investigate the factors associated with chemoresistance to neoadjuvant chemotherapy (NACT) followed by radical hysterectomy (RH) and construct a nomogram to predict the chemoresistance in patients with locally advanced cervical squamous carcinoma (LACSC).

Materials and methods: This retrospective study included 516 patients with International Federation of Gynecology and Obstetrics (2003) stage IB2 and IIA2 cervical cancer treated with NACT and RH between 2007 and 2017. Clinicopathologic data were collected, and patients were assigned to training (n=381) and validation (n=135) sets. Univariate and multivariate analyses were performed to analyze factors associated with chemoresistance to NACT. A nomogram was built using the multivariate logistic regression analysis results. We evaluated the discriminative ability and accuracy of the model using a concordance index and a calibration curve. The predictive probability of chemoresistance to NACT was defined as > 34%.

Results: Multivariate analysis confirmed menopausal status, clinical tumor diameter, serum squamous cell carcinoma antigen level, and parametrial invasion on magnetic resonance imaging before treatment as independent prognostic factors associated with chemoresistance to NACT. The concordance indices of the nomogram for training and validation sets were 0.861 (95% confidence interval [CI], 0.822 to 0.900) and 0.807 (95% CI, 0.807 to 0.888), respectively. Calibration plots revealed a good fit between the modelpredicted probabilities and actual probabilities (Hosmer-Lemeshow test, p=0.597). Furthermore, grouping based on the nomogram was associated with progression-free survival.

Conclusion: We developed a nomogram for predicting chemoresistance in LACSC patients treated with RH. This nomogram can help physicians make clinical decisions regarding primary management and postoperative follow-up of the patients.

Keywords: Chemoresistance; Neoadjuvant chemotherapy; Nomograms; Uterine cervical neoplasms.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Conflicts of interest relevant to this article was not reported.

Figures

Fig. 1
Fig. 1
Inclusion criteria. MRI, magnetic resonance imaging; NACT, neoadjuvant chemotherapy; SCC-Ag, squamous cell carcinoma antigen.
Fig. 2
Fig. 2
Nomogram predicting chemoresistance in patients with locally advanced cervical squamous carcinoma treated with neoadjuvant chemotherapy and radical hysterectomy. MRI, magnetic resonance imaging; SCC-Ag, squamous cell carcinoma antigen.
Fig. 3
Fig. 3
Receiver operating characteristic curve for prediction of chemoresistance based on nomogram model in training set (A) and validation set (B). Calibration plot for nomogram model in training set (C) and validation set (D). Green line, the ideal reference line, indicated the perfect prediction of ideal model; Blue line, the apparent line, represented the entire cohort in training set or validation set; Red line, the bias-corrected line, is bias-corrected by bootstrapping (B=1,000 repetitions), suggesting observed performance of current nomogram. AUC, area under curve; CI, confidence interval.
Fig. 4
Fig. 4
Progression-free survival plot based on grouping of nomogram model for chemoresistance.
Fig. 5
Fig. 5
Treatment-flow chart based on chemoresistance. NACT, neoadjuvant chemotherapy.
See this image and copyright information in PMC

References

    1. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22–36. - PubMed
    1. He D, Duan C, Chen J, Lai L, Chen J, Chen D. The safety and efficacy of the preoperative neoadjuvant chemotherapy for patients with cervical cancer: a systematic review and meta analysis. Int J Clin Exp Med. 2015;8:14693–700. - PMC - PubMed
    1. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer. 2003;39:2470–86. - PubMed
    1. Hsieh HY, Huang JW, Lu CH, Lin JC, Wang L. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/− neoadjuvant chemotherapy. J Formos Med Assoc. 2019;118:99–108. - PubMed
    1. Katsumata N, Yoshikawa H, Kobayashi H, Saito T, Kuzuya K, Nakanishi T, et al. Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102) Br J Cancer. 2013;108:1957–63. - PMC - PubMed